I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Vanucizumab mode of action: Serial biomarkers in plasma, tu..:
Heil, Florian
;
Babitzki, Galina
;
Julien-Laferriere, Alice
...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.tranon.2020.100984. , 2021
Link:
https://hal.science/hal-03141470
RT Journal T1
Vanucizumab mode of action: Serial biomarkers in plasma, tumor, and skin-wound-healing biopsies
UL https://suche.suub.uni-bremen.de/peid=base-ftuniversailles:oai:HAL:hal-03141470v1&Exemplar=1&LAN=DE A1 Heil, Florian A1 Babitzki, Galina A1 Julien-Laferriere, Alice A1 Ooi, Chia Huey A1 Hidalgo, Manuel M A1 Massard, Christophe A1 Martinez-Garcia, Mariá J A1 Le Tourneau, Christophe A1 Kockx, Mark M A1 Gerber, Peter A1 Rossomanno, Simona A1 Krieter, Oliver A1 Lahr, Angelika A1 Wild, Norbert A1 Harring, Suzana Vega A1 Lechner, Katharina PB HAL CCSD; Elsevier YR 2021 K1 Angiopoietin-2 K1 Biomarkers K1 Micro vessel density K1 Mode of action K1 Phase I clinical trial K1 Vanucizumab K1 [SDV.CAN]Life Sciences [q-bio]/Cancer K1 [SDV.SP.PHARMA]Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology JF info:eu-repo/semantics/altIdentifier/doi/10.1016/j.tranon.2020.100984 LK http://dx.doi.org/https://hal.science/hal-03141470 DO https://hal.science/hal-03141470 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)